Kombucha‑Related Infection

This guide provides a clear, evidence‑based overview of infections that can arise from kombucha tea – a fermented, slightly effervescent beverage that has become popular worldwide. It is written for the general public and patients who want to understand symptoms, diagnosis, treatment, and prevention.

Overview

Kombucha‑related infection refers to any illness caused by pathogenic microorganisms (bacteria, yeasts, or molds) that contaminate kombucha during brewing, bottling, or storage. The most common presentations are:

• Gastrointestinal (GI) infection – usually bacterial (e.g., Salmonella, E. coli) or fungal (e.g., Candida spp.).
• Fungal skin or soft‑tissue infection after handling contaminated SCOBY (Symbiotic Culture Of Bacteria and Yeast).
• Systemic infections in immunocompromised individuals (e.g., bloodstream infection with Acetobacter spp.).

While kombucha is generally safe when prepared under strict hygienic conditions, outbreaks have been reported in the United States, Europe, and Asia. According to the CDC, fermented drinks account for roughly 0.2 % of all reported food‑borne illness cases (≈ 2,000 cases per year in the U.S.). Exact numbers for kombucha alone are not tracked, but case reports in medical journals (e.g., Clinical Infectious Diseases, 2021) describe at least 30 confirmed infections worldwide between 2015‑2022.

Anyone who drinks commercially‑produced kombucha or brews it at home can be affected, but certain groups are at higher risk:

• People with weakened immune systems (cancer, HIV/AIDS, organ transplant recipients, chronic steroid use).
• Pregnant or breastfeeding women – due to uncertain microbial load.
• Individuals with pre‑existing GI disorders (IBS, ulcerative colitis) who may be more sensitive to changes in gut flora.

Symptoms

Symptoms vary by the type of pathogen and the site of infection. Below is a comprehensive list, grouped by system.

Gastrointestinal Symptoms

• Nausea & vomiting – sudden onset, often within 6‑24 hours after ingestion.
• Abdominal cramping – described as sharp or colicky pain.
• Diarrhea – watery, sometimes bloody if invasive bacteria are involved.
• Fever – low‑grade (≤38 °C) to high (≥39 °C) depending on severity.
• Loss of appetite and general malaise.

Systemic/Feverish Symptoms

• Chills and rigors.
• Headache.
• Muscle aches (myalgia).
• Fatigue lasting days to weeks.

Skin and Soft‑Tissue Symptoms (from handling contaminated SCOBY)

• Redness, swelling, and warmth at the site of contact.
• Itching or burning sensation.
• Development of pustules or ulcerations – may indicate fungal (e.g., Candida) or bacterial infection.

Rare but Severe Manifestations

• Septicemia – fever, low blood pressure, confusion (requires immediate care).
• Endocarditis – heart valve infection, presenting with persistent fever, heart murmur, and shortness of breath.
• Central nervous system involvement – headache, neck stiffness, seizures (extremely rare).

Causes and Risk Factors

The infection does not stem from kombucha itself – a properly fermented brew contains predominantly harmless acetic‑acid bacteria (Acetobacter) and yeasts (Saccharomyces). Problems arise when:

1. Contamination occurs during brewing. Using non‑sterile equipment, unclean water, or exposed SCOBY can introduce pathogenic microbes.
2. Improper fermentation temperature. Temperatures above 30 °C favor growth of harmful bacteria.
3. Extended storage. Over‑fermentation can raise alcohol content (>0.5 %) and lower acidity, creating an environment where pathogens survive.
4. Cross‑contamination with other foods. Storing kombucha near raw meats or unwashed produce.

Risk Factors

• Home brewing without standardized protocols – 70 % of reported cases involve homemade batches (Mayo Clinic, 2022).
• Use of commercially unavailable “wild” SCOBYs – genetic diversity increases chance of exotic pathogens.
• Compromised immunity – weaker defenses make even low‑level contamination clinically significant.
• Pregnancy – altered gut motility and immune modulation.
• Pre‑existing GI disease – altered mucosal barrier.

Diagnosis

Because symptoms overlap with many common GI infections, a systematic approach is essential.

Clinical Evaluation

• Detailed history – recent consumption of kombucha (brand, home‑brewed vs. commercial, quantity, timing).
  
• Review of brewing practices if homemade (equipment, fermentation time, temperature).
• Physical exam focusing on abdomen, skin, and vital signs.

Laboratory Tests

1. Stool culture – identifies bacterial pathogens (e.g., Salmonella, Campylobacter).
2. Stool PCR panel – rapid detection of viral, bacterial, and parasitic DNA (CDC’s FilmArray GI Panel).
3. Fungal culture or KOH prep – for skin lesions or if Candida infection suspected.
4. Blood cultures – indicated if systemic signs (fever >39 °C, hypotension) are present.
5. Complete blood count (CBC) and C‑reactive protein (CRP) – gauge inflammation.

Imaging (if indicated)

• Abdominal CT or ultrasound for severe abdominal pain, suspected colitis, or abscess formation.
• Echocardiogram if endocarditis is a concern (rare but reported in immunocompromised hosts).

Treatment Options

Treatment is tailored to the identified pathogen, severity, and patient’s health status.

General Measures

• Hydration – oral rehydration solutions (ORS) or IV fluids for moderate‑to‑severe dehydration.
• Dietary adjustments – bland BRAT diet (bananas, rice, applesauce, toast) until symptoms improve.
• Stop kombucha consumption immediately.

Antimicrobial Therapy (Pathogen‑Specific)

Pathogen	First‑Line Treatment	Duration
Salmonella (non‑typhoidal)	Ciprofloxacin 500 mg PO BID or Azithromycin 500 mg PO daily	5‑7 days
E. coli (ETEC/EAEC)	Supportive care; antibiotics only if severe – Rifaximin 550 mg PO BID	3 days
Clostridioides difficile	Vancomycin 125 mg PO QID	10 days
Candida spp. (skin)	Topical azoles (clotrimazole 1 % cream) or oral fluconazole 100 mg PO daily	7‑14 days
Gram‑positive bacteremia (e.g., Enterococcus)	IV ampicillin + gentamicin or daptomycin	2‑4 weeks

Adjunctive Therapies

• Probiotics – strains such as Lactobacillus rhamnosus GG may aid gut flora restoration after antibiotics (NIH, 2023).
• Analgesics/antipyretics – acetaminophen or ibuprofen for fever and pain.

When Hospitalization is Needed

• Severe dehydration or electrolyte imbalance.
• High‑grade fever (>39 °C) persisting >48 h.
• Signs of systemic infection (hypotension, tachycardia, altered mental status).
• Immunocompromised patients with any fever.

Living with Kombucha‑Related Infection

Even after acute illness resolves, patients may need ongoing care to prevent relapse and support recovery.

Daily Management Tips

• Hydration – aim for at least 2‑3 L of water/day; use ORS if diarrhea persists.
• Nutrition – incorporate easily digestible proteins (yogurt, boiled chicken) and soluble fiber (oatmeal) to rebuild gut lining.
• Medication adherence – complete the full antibiotic or antifungal course, even if symptoms improve.
• Monitor bowel habits – record frequency, consistency, and any blood/mucus.
• Skin care – keep any affected area clean, dry, and use prescribed topical agents.

Follow‑Up

• Re‑evaluate with your clinician 1‑2 weeks after finishing therapy to ensure symptom resolution.
• Repeat stool culture if diarrhea persists beyond 7 days post‑treatment.
• Immunocompromised patients should have blood work (CBC, CRP) checked 2 weeks after discharge.

Prevention

Most kombucha infections are preventable with proper hygiene and awareness.

For Home Brewers

• Use sterile equipment – wash jars, lids, and SCOBY with hot, soapy water and rinse thoroughly.
• Boil water for at least 1 minute before cooling to brewing temperature (20‑30 °C).
• Maintain a consistent fermentation temperature (21‑27 °C). Use a thermometer.
• Cover fermenting vessels with tightly‑fitting cloth or paper towel secured with a rubber band – avoid direct exposure to airborne contaminants.
• Limit fermentation time: 7‑14 days for most recipes; longer periods increase risk.
• Store finished kombucha in the refrigerator (≤4 °C) and consume within 7‑10 days.
• Discard any batch with off‑odors, visible mold (green/black fuzz), or abnormal cloudiness.

For Commercial Consumers

• Choose brands that follow Good Manufacturing Practices (GMP) and have a clear expiration date.
• Check the label for alcohol content ≤0.5 % (U.S. regulation) and pH ≤ 3.5, indicating adequate acidity.
• Inspect the bottle – no bulging caps or foul smell, which may signal fermentation in the bottle.

General Public Health Measures

• Wash hands with soap for at least 20 seconds before handling kombucha or any food.
• Avoid giving kombucha to children under 4 years, pregnant women, or immunocompromised persons unless it is commercially pasteurized.
• Educate family members about safe brewing techniques (many community health centers offer workshops).

Complications

If left untreated or inadequately managed, kombucha‑related infection can lead to:

• Dehydration & Electrolyte Imbalance – especially dangerous for the elderly and infants.
• Acute kidney injury from severe diarrhea.
• Septicemia – bacteria entering the bloodstream, with mortality rates up to 25 % in high‑risk groups (WHO, 2022).
• Chronic post‑infectious irritable bowel syndrome (IBS) – persistent abdominal pain and altered bowel habits.
• Fungal cellulitis – may require surgical debridement.
• Endocarditis or osteomyelitis in rare cases of prolonged bacteremia.

When to Seek Emergency Care

Prompt medical attention can prevent serious complications and improve outcomes.

---

Sources: Mayo Clinic. “Fermented foods and safety.” 2022; CDC Foodborne Illness Reports, 2023; NIH National Institute of Allergy and Infectious Diseases, “Probiotics in GI infection,” 2023; WHO Global Health Estimates, 2022; Clinical Infectious Diseases, “Kombucha‑associated bacteremia: case series,” 2021; Cleveland Clinic. “Home brewing safety guidelines,” 2024.